Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Oncologix Tech Inc. (OCLG : OTC)
 
 • Company Description   
BestNet is a facilities based provider of web-based communication and long distance phone carrier services based on proprietary technology. Helping people communicate globally is the company mission, which is achieved with the deployment of innovative and feature-rich long distance dialing and teleconference calling services for use by customers.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.00 Daily Weekly Monthly
20 Day Moving Average: 9,372,550 shares
Shares Outstanding: 1,662.47 (millions)
Market Capitalization: $3.99 (millions)
Beta: 2.06
52 Week High: $0.02
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -66.20% -61.93%
12 Week -17.24% -9.02%
Year To Date -73.63% -66.43%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1604 West Pinhook Road Suite # 200
-
Lafayette,LA 70508
USA
ph: 616-977-9933
fax: 616-977-9955
None None
 
 • General Corporate Information   
Officers
Roy Wayne Erwin - C.E.O.; President and Director
Victoria Hart - President
Michael Kramarz - Chief Financial Officer; Secretary
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 68230M209
SIC: 3841
Fiscal Year
Fiscal Year End: August
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 1,662.47
Most Recent Split Date: 5.00 (0.25:1)
Beta: 2.06
Market Capitalization: $3.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
02/28/22 - -
11/30/21 - -
08/31/21 - -
ROA
02/28/22 - -
11/30/21 - -
08/31/21 - -
Current Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Quick Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Operating Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Net Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Pre-Tax Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Book Value
02/28/22 - -
11/30/21 - -
08/31/21 - -
Inventory Turnover
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Equity
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Capital
02/28/22 - -
11/30/21 - -
08/31/21 - -
 

Powered by Zacks Investment Research ©